Plasma catecholamine concentrations were measured after vasoconstrictor solutions were administered either by instillation (Moffett's method) 
hydraulic dissection of the mucoperichondrial flaps from the septal cartilage, which facilitates the surgery, While vasoconstriction for purely intranasal procedures may be produced by either method, infiltration is usually preferred when a rhinoplasty is performed in conjunction with the intransal surgery,3,4 With the upsurge in functional endoscopic sinus surgery, infiltration of vasoconstrictors in the nose in being used with increasing frequency.
The ability of adrenaline to induce cardiac arrhythmia is well known and attempts have been made to define safe doses of adrenaline. 5 However, while plasma concentrations of adrenaline following infiltration for nasal surgery have been measured previously, I the levels have not been compared between infiltration and topical administration. Hence this study was undertaken to measure catecholamine levels in patients undergoing septal surgery in order to assess differences in systemic absorption following two routine methods of nasal preparation.
PATIENTS AND METHODS undergoing elective septoplasty were studied.
Twenty consecutive adult ( > 16 years) patients
Patients with a history of cardiovascular disease, respiratory disease, an abnormal ECG or chest radiograph were excluded. The patients were randomly allocated into two groups to receive adrenaline either by infiltration (INF) or by instillation (MOFF). All patients gave informed consent prior to inclusion in the study, which was approved by the Research Ethics Committee of the Chinese University of Hong Kong. Premedication consisted of diazepam 10 mg given orally 1 to 1.5 hours before induction of anaesthesia. During induction, a 16-gauge cannula was inserted intravenously (IV) under local analgesia (plain lignocaine 1.5%) to establish IV access. Pulse oximetry, blood pressure and ECG in the anterior lead CM5 configuration were monitored. General anaesthesia was induced with thiopentone (4 mg.kg -I) and when the eyelash reflex was abolished, alcuronium (0.3 mg.kg-I ) was administered. Ventilation was maintained with a facemask with 33% oxygen in nitrous oxide until endotracheal intubation was performed. A saline-soaked gauze throat-pack was inserted. Anaesthesia was maintained by intermittent positive pressure ventilation with 1 % enflurane and 33% oxygen in nitrous oxide.
Methods of vasoconstriction (a) Infiltration (INF)
Patients in this group received local infiltration of 4.4 ml 1:80,000 adrenaline and 2% lignocaine (ASTRA Pharmaceuticals) in addition to topical application of 5 ml 5% cocaine solution on ribbon gauze packs placed into the nasal cavity. This constitutes a total dose of 12.5 mcg adrenaline.
Subjects in this group received intranasal application of Moffett's solution. 6 This solution consists of 1 ml 1 : 1000 adrenaline, 2 ml 10% cocaine and 2 ml 1 % sodium bicarbonate, made up to 20 ml by adding sterile water. 7 This solution was introduced into the nostril with the patient in Moffett's position, with the head and.neck fully extended so that the solution pooled in the nasal cavities. The total dose of adrenaline in this solution is 1000 mcg.
Samples and catecholamine assay
Following a ten-minute period of undisturbed anaesthesia, a blood sample was drawn as the baseline (Control) sample. The patient was positioned and prepared for surgery. At the start of either infiltration or instillation of the vasoconstrictor solution, a venous blood sample was drawn (Sample 0). Further samples were then taken at 1, 2, 3, 4,5,10,15,20,25 and 30 minutes. The blood samples were drawn into chilled lithium heparin tubes and kept on ice until the last sample Anaesthesia and Intensive Care, Vol. 20, No. 3, August, 1992 had been drawn. They were then immediately coldspun (3000 rpm at 4°C) and assays were undertaken on the same day. Adrenaline and noradrenaline assays were performed in duplicate by high pressure liquid chromatography using a method modified after Causon et al. (1981) . 8 We used alumina extraction of the catecholamines after the method of Lund, 9 and analysed the samples on a reversed phased ODS C18 column (Beckmann ODS IP). Detection of the analyte was undertaken by the electrochemical method, on a sensitive coulometric detector (ESA 51 OOA). The coefficient of variation was 5.7% for noradrenaline (NA) and 9.07% for adrenaline (AD). Interassay coefficient of variation was 7.15% and the assay was linear to the lower limit of detection, which was 25 pg/ml or 0.136 nmol.l-I .
Surgery, blood loss and the operative field
The operation was started exactly ten minutes after the start of the application of the vasoconstrictor. Three surgeons performed the procedures which were standard septoplasties. The time taken for the operation was measured from the start of the incision to the placement of the nasal packs and recorded in each case.
The operative field was subjectively assessed by the surgeon (who was aware of the type of vasoconstrictor which had been applied) and categorised as excellent, good, average, or poor. An estimate of the blood loss was made by collecting all of the aspirate into a graduated bottle. At the end of the procedure saline was flushed through the suction system to collect all blood from the tubing. The volume was then made up to 50 ml with additional saline. The blood loss was calculated from measurement of the haemoglobin of this solution and the patient's haemoglobin. lo Student's t test was used to compare variables of the two nasal preparation groups. P < 0.05 was considered significant. Data are presented as means ± SE unless indicated. Plasma catecholamine concentrations refer to venous plasma samples.
RESULTS
Demographic data of the two groups of patients are shown in Table 1 . Both groups were similar with regard to age, sex and weight. All were American Society of Anesthesiology (ASA) I status. Mean and standard error of the plasma catecholamine concentrations are presented in Figures 1 to 4 . Both groups of patients showed no significant changes in plasma noradrenaline over 30 minutes (Figures 1  and 2 ). There was a considerable rise in plasma adrenaline to peak level of 9.9 nmol.l-I as measured in the one-minute sample from those patients where the vasoconstrictor solution was administered by infiltration ( Figure 3 Table 2 ).
DISCUSSION
The aim of this study was to measure the intravascular absorption of adrenaline from solutions administered by two different methods for the purposes of vasoconstriction. Both of these methods for vasoconstriction of the nasal mucosa are well-established. However, the safety of these widely used techniques for improving the surgical field has always been presumed and there has been no data to define the degree of intravascular catecholamine absorption. These findings show that a rapid rise to a peak concentration of 9.9 ± 2.34 nmol.l-1 , which is forty-four times basal value, occurs within the first minute after infiltration ( Figure 3 ). It is possible that the actual peak concentrations of adrenaline occur within one minute, but in practice it is difficult to draw blood samples more frequently than at one-minute intervals. The amount absorbed into the systemic circulation represents 67% of the total administered dose. With topical application by Moffett's method, the peak concentrations were much lower at 1.27 ± 0.18 nmol.1 -1) (P < 0.01) and plasma concentrations increase more gradually over 15 to 20 minutes following infiltration (Figure 4 ). Only 0.14% of the total administered dose was absorbed into the circulation. Plasma concentrations of catecholamines vary widely according to physiological and pathological conditions. Physiological venous plasma adrenaline and noradrenaline concentrations range respectively from about 0.2 and 1.0 nmol.l-1 ) at rest, to over 2 and 10 nmol.l -1) during heavy exercise. 11 Adrenaline is secreted by the adrenal medulla in response to sympathetic nervous system activation, whereas noradrenaline spills over into the plasma after release from the sympathetic nerve endings. 12 Adrenaline is extracted from the circulation by peripheral tissues, but the kinetic details are unknownY Noradrenaline is removed by re-uptake into the sympathetic nerve endings. 12 Venous blood concentration also reflects the noradrenaline released from sympathetic nerves supplying tissues which are drained by the sampling vein. 13 In the present study, an absence of significant activation of the sympathetic nervous system was demonstrated by relatively constant plasma noradrenaline concentrations.
Excellent Good Average
It has been established that, following infiltration of adrenaline-containing solutions in the cervix, the peak plasma concentration of catecholamine occurred within the first few minutes of administration. 14 We therefore chose to sample at one-minute intervals for the first five minutes and at five-minute intervals thereafter. Other studies in which a sample was obtained at two-minute intervals have failed to demonstrate such rapid and high peak plasma concentrations within the first minute.I,ls Since approximately one-third of circulating catecholamines are extracted during the passage through the pulmonary circulation, the measurement of the peak concentration might have been higher had the samples been drawn from a mixed venous site. However, the insertion of central venous catheters for the purposes of obtaining mixed venous samples was not considered justifiable in this study. Even so the peak concentrations of adrenaline noted in this study were well above those encountered in untreated phaeochromocytoma. 16 Further studies on much larger numbers of patients would be needed to establish the risk of developing serious cardiac dysrrythmias, hypertension or myocardial ischaemia. Blood loss was less, and subjective assessment favoured the operative field in the INF group. However operative conditions were noted to be adequate in the MOFF group. The time taken for the procedure was shorter in the INF group, which may reflect easier dissection of the mucoperichondrial flaps and more favourable operative conditions.
The clinical, more especially cardiac, consequences of the intravascular absorption of adrenaline remain to be defined. The patients in this study experienced no cardiac dysrhythmias or episodes of hypertension that required treatment. The precautionary use of enflurane as an alternative to halothane and the healthy status of the patients may have been contributory to the lack of dysrhythmias. In the light of these findings instillation rather than infiltration of vasoconstrictor solutions should be employed when nasal surgery is undertaken in subjects who may be considered at risk for cardiac dysrhythmias.
We conclude that the submucosal infiltration of 4.4 ml of 1:80,000 adrenaline to the nasal septum results in a forty-four-fold rise in venous plasma adrenaline concentrations. This represents 67% of the total dose administered. The peak absorption occurs within minutes of administration and close monitoring, especially of the electrocardiograph and blood pressure, is recommended.
